Evidence map›Paper›PMID 21980400›Full record

ArticlePloS one2011

PI3K and ERK-induced Rac1 activation mediates hypoxia-induced HIF-1α expression in MCF-7 breast cancer cells.

Jun Du, Rui Xu, Zhenzhen Hu, Yinhui Tian, Yichao Zhu, Luo Gu, Lei Zhou

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 101 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Adipose Tissue Hypoxia in Obesity: Clinical Reappraisal of Hypoxia Hypothesis.Advances in experimental medicine and biology · 2024
    Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Cross-Talk between Oxidative Stress and mOxidative medicine and cellular longevity · 2021
    Review
  14. Review
  15. Article
  16. Article
  17. The Rho GTPase RAC1 in Osteoblasts Controls Their Function.International journal of molecular sciences · 2020
    Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jun DuState Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, China.
Rui Xu
Zhenzhen Hu
Yinhui Tian
Yichao Zhu
Luo Gu
Lei Zhou
Nanjing Medical University · CNJiangsu Province Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHypoxia-inducible factor 1 (HIF-1α) expression induced by hypoxia plays a critical role in promoting tumor angiogenesis and metastasis. However, the molecular mechanisms underlying the induction of HIF-1α in tumor cells remain unknown. METHODOLOGY/PRINCIPAL

findingsIn this study, we reported that hypoxia could induce HIF-1α and VEGF expression accompanied by Rac1 activation in MCF-7 breast cancer cells. Blockade of Rac1 activation with ectopic expression of an inactive mutant form of Rac1 (T17N) or Rac1 siRNA downregulated hypoxia-induced HIF-1α and VEGF expression. Furthermore, Hypoxia increased PI3K and ERK signaling activity. Both PI3K inhibitor LY294002 and ERK inhibitor U0126 suppressed hypoxia-induced Rac1 activation as well as HIF-1α expression. Moreover, hypoxia treatment resulted in a remarkable production of reactive oxygen species (ROS). N-acetyl-L-cysteine, a scavenger of ROS, inhibited hypoxia-induced ROS generation, PI3K, ERK and Rac1 activation as well as HIF-1α expression. CONCLUSIONS/SIGNIFICANCE: Taken together, our study demonstrated that hypoxia-induced HIF-1α expression involves a cascade of signaling events including ROS generation, activation of PI3K and ERK signaling, and subsequent activation of Rac1.

Indexed as

Breast NeoplasmsButadienesCell HypoxiaCell Line, TumorChromonesExtracellular Signal-Regulated MAP KinasesHumansHypoxia-Inducible Factor 1, alpha SubunitMorpholinesNitrilesPhosphatidylinositol 3-KinasesPhosphoinositide-3 Kinase Inhibitorsrac1 GTP-Binding ProteinReactive Oxygen Species2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-oneButadienesChromonesExtracellular Signal-Regulated MAP KinasesHypoxia-Inducible Factor 1, alpha SubunitMorpholinesNitrilesPhosphatidylinositol 3-KinasesPhosphoinositide-3 Kinase Inhibitorsrac1 GTP-Binding ProteinReactive Oxygen SpeciesU 0126

Identifiers

PMID21980400
PMCPMC3181265
OpenAlexW2115773204

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.